Autoimmune Diseases of the Nervous System: all 114 studies
Page 2 of 2. Open to participants first (56), then studies with results posted, then the rest; newest registration first within each.
- Safety and Efficacy of Melatonin in Patients With Multiple Progressive Primary SclerosisTerminatedNCT03540485Phase 1/2
- To Explore Cognitive Neural Mechanism of Autoimmune Encephalitis by Using Neuropsychological Tests and Multi-modal MRICompletedNCT03530462
- Reverse Transcriptase Inhibitors in Aicardi Goutières SyndromeWithdrawnNCT03304717Phase 1/2
- IVIG and Rituximab in Antibody-associated Psychosis - SINAPPS2Active, not recruitingNCT03194815Phase 2
- Effect of Erythropoietin in Refractory Autoimmune Encephalitis PatientsWithdrawnNCT03004209Phase 4
- Effect of Vigabatrin in Refractory Autoimmune Encephalitis PatientsWithdrawnNCT03003143Not applicable
- Mechanisms of Auto-immune EncephalitisCompletedNCT02905136
- Antibodies Causing Epilepsy Syndromes: The ACES Study.CompletedNCT02802475
- IL-2 in Refractory Autoimmune EncephalitisCompletedNCT02714959Phase 1/2
- Study of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple SclerosisCompletedNCT01684761Phase 2
- Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered Into Patients With Multiple SclerosisWithdrawnNCT01453764Not applicable
- Autologous Mesenchymal Stem Cells From Adipose Tissue in Patients With Secondary Progressive Multiple SclerosisCompletedNCT01056471Phase 1/2
- Autologous Stem Cell Transplant for Neurologic Autoimmune DiseasesActive, not recruitingNCT00716066Phase 2
- A Pilot Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis Optica (Devic's Disease)CompletedNCT00304291Phase 4